Masashi Kishida
Masashi Kishida, Hyogo JP
Patent application number | Description | Published |
---|---|---|
20110098293 | Inhibitors of Protein Tyrosine Kinase Activity - This invention relates to compounds that inhibit protein tyrosine kinase activity. In particular the invention relates to compounds that inhibit the protein tyrosine kinase activity of growth factor receptors, resulting in the inhibition of receptor signaling, for example, the inhibition of VEGF receptor signaling. The invention also provides compounds, compositions and methods for treating cell proliferative diseases and conditions and opthalmological diseases, disorders and conditions. | 04-28-2011 |
20140179632 | METHODS OF INHIBITING PROTEIN TYROSINE KINASE ACTIVITY - This invention relates to methods for inhibiting kinase activity and/or inhibiting angiogenesis and/or treating a disease responsive to inhibition of kinase activity and/or treating a cell proliferative disease and/or treating an ophthalmic disease, condition or disorder treating cell proliferative diseases and conditions and opthalmological diseases, disorders and conditions comprising administering novel compounds that inhibit protein tyrosine kinase activity. | 06-26-2014 |
Masashi Kishida, Ako-Shi JP
Patent application number | Description | Published |
---|---|---|
20110077240 | INHIBITORS OF PROTEIN TYROSINE KINASE ACTIVITY - This invention relates to compounds that inhibit protein tyrosine kinase activity. In particular the invention relates to compounds that inhibit the protein tyrosine kinase activity of growth factor receptors, resulting in the inhibition of receptor signaling, for example, the inhibition of VEGF receptor signaling. The invention also provides compounds, compositions and methods for treating cell proliferative diseases and conditions and opthalmological diseases, disorders and conditions. | 03-31-2011 |
20110257100 | Inhibitors of Protein Tyrosine Kinase Activity - This invention relates to compounds that inhibit protein tyrosine kinase activity. In particular the invention relates to compounds that inhibit the protein tyrosine kinase activity of growth factor receptors, resulting in the inhibition of receptor signaling, for example, the inhibition of VEGF receptor signaling. The invention also provides compounds, compositions and methods for treating cell proliferative diseases and conditions and ophthalmic diseases, disorders and conditions. | 10-20-2011 |
Masashi Kishida, Tsukuba JP
Patent application number | Description | Published |
---|---|---|
20100041705 | Organic Compounds - The present invention provides a compound of formula (I): | 02-18-2010 |
20100076021 | Organic Compounds - The present invention provides a compound of formula (I): | 03-25-2010 |
20100173896 | Organic Compounds - The present invention relates to novel benzodiazepine compounds exhibiting RXR-antagonist efficacy, to the manufacture and to the use thereof. | 07-08-2010 |
Masashi Kishida, Ibaraki JP
Patent application number | Description | Published |
---|---|---|
20090048230 | COMPOUNDS AND COMPOSITIONS USEFUL AS CATHEPSIN S INHIBITORS - The present invention relates to the use of a 2-cyanopyrimidine compound of the formula | 02-19-2009 |
20090075968 | CETP inhibitors - The present invention relates to a compound of formula | 03-19-2009 |
20090227580 | Bicyclic derivatives as CETP inhibitors - The present invention relates to novel compounds of formula (I) | 09-10-2009 |
20120225874 | BICYCLIC DERIVATIVES AS CETP INHIBITORS - The present invention relates to novel compounds of formula (I) | 09-06-2012 |
Masashi Kishida, Osaka JP
Patent application number | Description | Published |
---|---|---|
20130096088 | Inhibitors of Protein Tyrosine Kinase Activity - The present invention provides new compounds and methods for treating a disease responsive to inhibition of kinase activity, for example a disease responsive to inhibition of protein tyrosine kinase activity, for example a disease responsive to inhibition of protein tyrosine kinase activity of growth factor receptors, for example a disease responsive to inhibition of receptor type tyrosine kinase signaling, or for example, a disease responsive to inhibition of VEGF receptor signaling. | 04-18-2013 |
20130096135 | Selected Inhibitors of Protein Tyrosine Kinase Activity - The present invention provides new compounds and methods for treating a disease responsive to inhibition of kinase activity, for example a disease responsive to inhibition of protein tyrosine kinase activity, for example a disease responsive to inhibition of protein tyrosine kinase activity of growth factor receptors, for example a disease responsive to inhibition of receptor type tyrosine kinase signaling, or for example, a disease responsive to inhibition of VEGF receptor signaling. | 04-18-2013 |
20140315801 | METHODS OF TREATMENT OF CELL PROLIFERATIVE AND/OR OPHTHALMIC DISEASES, DISORDERS AND CONDITIONS USING INHIBITORS OF PROTEIN TYROSINE KINASE ACTIVITY - This invention relates to methods for treating cell proliferative diseases and conditions and ophthalmic diseases, disorders and conditions using compounds that inhibit protein tyrosine kinase activity. In particular the invention relates to the methods of treatment which utilize compounds that inhibit the protein tyrosine kinase activity of growth factor receptors, resulting in the inhibition of receptor signaling, for example, the inhibition of VEGF receptor signaling. | 10-23-2014 |